Market Insights:
Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to the fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of the musculoskeletal system, which include trauma, the spine, the hand, and upper extremity, total joints, and even pediatric orthopedics.
The report titled “Orthopedic Oncology Treatment Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2023” offers strategic insights into the overall orthopedic oncology treatment market, along with the market size and estimates for the duration of 2016 to 2023. The said research study covers an in-depth analysis of multiple market segments based on types of procedures and different geographical regions. The procedure type segments studied for analyzing the overall orthopedic oncology treatment market are soft tissue excisions and resections, limb salvage surgery, amputation, adjuvant chemotherapy, and reconstructive surgery. Reconstructive surgery holds the largest share in the global orthopedic oncology market owing to the developments in prosthetics and bone grafting techniques that are being accepted by patients. The limb salvage surgery market is expected to grow at a subtle rate due to its cost-effective nature, so the adjuvant chemotherapy segment would grow at a steady rate.
In order to help strategic decision-makers, the report also includes competitive profiling of the leading players in the orthopedic oncology treatment market and attractive investment propositions and market positioning of key manufacturers sections.
The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global orthopedic oncology treatment market. Tools such as the market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global orthopedic oncology treatment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the orthopedic oncology treatment market. In-depth competitive environment analysis and historical years (2013 and 2014) of market size data are also provided in the report.
Thus, the research study provides a holistic view of the global orthopedic oncology treatment market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.
Based on the types of procedures, the global orthopedic oncology treatment market is segmented as follows:
- Soft-tissue excisions and resections
- Limb salvage surgery
- Amputation
- Adjuvant Chemotherapy
- Reconstructive Surgery
- Hip and Joint Replacement
- Bone Grafts
Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to the fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of the musculoskeletal system, which include trauma, the spine, the hand, and upper extremity, total joints, and even pediatric orthopedics. However, the field of orthopedic oncology continues to be invigorated by exhilarating research and developments that have enhanced the level of treatment and care for patients with various bone and soft-tissue tumors. Currently, most patients with primary bone sarcomas are offered limb-salvage surgery without increasing the risk of survival at the sarcoma centers. Moreover, the advances in imaging techniques and surgical techniques have further improved the treatment of patients with bone and soft-tissue malignancies. Orthopedic oncologists continue to collaborate with other subspecialists to integrate advances in surgical techniques. This is especially true for the development of implants and image-guided surgery.
The global orthopedic oncology treatment market has been segmented by type of procedure into soft tissue excisions and resections, limb salvage surgery, amputation, adjuvant chemotherapy, and reconstructive surgery. The reconstructive surgery is further sub-segmented into hip and joint replacement and bone grafts. Reconstructive surgery has the largest share of the global orthopedic oncology treatment market. The bone grafting techniques are anticipated to grow at the highest rate during the forecast period owing to the advances in the fields of prosthesis and endoprosthesis.
For the purpose of this study, the global orthopedic oncology treatment market is categorized as follows:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
For the purpose of this study, the global orthopedic oncology treatment market is categorized into six regional markets: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year of 2015, Asia Pacific was observed as the largest market for orthopedic oncology. Large disease prevalence, along with the growing healthcare ecosystem in the region, have assisted the growth of the orthopedic oncology market in Asia-Pacific. Moreover, growth in the medical tourism industry in the region in the last decade has further fueled the market for orthopedic oncology treatment in Asia-Pacific. Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem in the country. In India, the incidence of bone cancer is 1/100 of all cancer cases, but it contributes to about 6–7% of pediatric cancer patients. Latin America, the Middle East, and Africa have emerged as the most potential markets due to the high prevalence of osteosarcoma and the lower treatment options available in the region. Hence, these markets would exhibit a strong growth rate during the forecast period with the development of the healthcare infrastructure.
